Specialty Pharmacy

Mark Tesell, PharmD, BCPS, clinical consultant pharmacist at UMass Medical School, discusses the treatment switch from statins to PCSK9 inhibitors in patients with high cholesterol.

Top news of the day from across the health care landscape.

New strategy helps slow kidney disease progression that can occur in diabetes.

New insights pave the way for future treatment developments of pancreatic ductal adenocarcinoma.

HIV Test-and-Treat initiates antiretroviral therapy promptly, but may be too expensive to employ nationwide.

Top news of the week in oncology, and cancer drug development.

New mouse study suggests that exposure to endocrine disrupting chemicals may cause resistance to tamoxifen therapy in some breast cancers.

Ocrelizumab (Ocrevus) may improve treatment of relapsing multiple sclerosis and primary progressive multiple sclerosis.

With few advancements in treatment options, a new immunotherapy treatment could lead to better outcomes in pancreatic cancer.

Some individuals produce antibodies that can recognize HIV.

Mice treated with drugs that block a dopamine receptor inhibited cancer growth.

Top stories of the week from Specialty Pharmacy Times.

Jonathan Van Lare, PharmD, director of Clinical Services at Pharmacy Advantage, discusses the impact of oncology medications and how specialty pharmacies can adjust.

New findings demonstrating differing mechanisms may contribute to a better understanding of acquired resistance to combination drug treatment in cancer.

A streamlined process for drug manufacturing may reduce prescription medication costs.

High body mass index linked to 10 types of cancer, including cancers of the breast, bowel, esophageal, and womb.

Partnership between Walgreens and EnvisionRx focuses on improving outcomes and adherence in patients with chronic conditions.

People of color who are underrepresented in multiple sclerosis clinical trials need to be engaged.

Mutation prevents the development of fibrosis in disease that mimics inflammatory bowel disease.

Risk of developing mental health issues were found to be lower in chronic obstructive pulmonary disease patients who are more active.

Mark A. Vineis, vice president of Specialty Pharmacy of Cardinal Health, discusses how the increased interest of the federal government in escalating drug prices may impact specialty pharmacy.

Top news of the day from across the healthcare landscape.

Top news of the day from across the health care landscape.

Chemotherapy alone leaves behind dormant cells, but when combined with immunotherapy, it can destroy most of the dormant cells.

HIF-2 inhibitors may be better tolerated and more effective in kidney cancer.

The size and scope of specialty pharmacy accreditation criteria has grown throughout the years.

HIV can increase hospitalization for mental health issues compared with the general population.

Inhibiting immune cells’ oxygen-sensing capability prevented lung metastasis in mice.